相关实验视频

Updated: May 11, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.2K

目前关于PSMA PET/CT在中等风险前列腺癌中的见解:文献综述

Priscilla Guglielmo1,2, Nicolò Buffi3,4, Angelo Porreca5

  • 1Nuclear Medicine Unit, Humanitas Gavazzeni, Bergamo, Italy. priscilla.guglielmo@yahoo.it.

Annals of nuclear medicine
|January 15, 2025
PubMed
概括

在中等风险前列腺癌 (PCa) 中,PSMA PET/CT 显示出识别高度疾病和预测淋巴结参与的潜力. 然而,它在这些患者的治疗策略和预后分层中的确切作用仍未确定,需要进一步研究.

关键词:
中间风险是中间风险.淋巴结的参与 淋巴结的参与在PSMA PET中,前列腺癌是什么意思 前列腺癌是什么意思这是一辆SUVmax,SUVmax.

更多相关视频

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

9.8K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

128

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...